Clinical Trial Update: Apatinib Treatment for Advanced Esophagus Cancer [Phase 2]

View source ↗

Summary

This document provides an update on a Phase 2 clinical trial of apatinib in patients with advanced esophageal cancer; the current status is not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• Apatinib (apatinib)

Snippet

Sponsor: Henan Cancer Hospital | Conditions: Advanced Esophagus Cancer | Phase 2 | Status: UNKNOWN